Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC 13:1_16:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003792 AN006234 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Maple syrup urinary disease University of Colorado Denver LC-MS
ST003792 AN006234 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Metabolic disease University of Colorado Denver LC-MS
ST003184 AN005229 A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis - tumor lipidomics Tumor cells Mouse Cancer University of Colorado Anschutz Medical Campus LC-MS
  logo